Content was developed by PRI Healthcare Solutions, a division of Haymarket Media, Inc. Advertising support received from Seattle Genetics, Inc. Seattle Genetics, Inc. did not influence or provide oversight over content.
In this video, breast medical oncologist, Carey Anders, MD, medical director of the Duke Center for Brain and Spine Metastasis at the Duke Cancer Institute in Durham, North Carolina, discusses treatment challenges in patients with locally advanced unresectable or metastatic HER2-positive breast cancer. Dr Anders also reviews data presented at the 2019 San Antonio Breast Cancer Symposium, highlighting novel therapeutic approaches that are currently in development.
